Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Versailles Hospital50 enrolled

Overview

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU. This is a monocentric interventional study (RIPH 2).

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Deep Vein Thrombosis

Interventions

Doppler EchoOTHER

2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient \> or =18 years * Hospitalization in intensive care * PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs Exclusion Criteria: * Pregnancy in progress * Patient \<18 years * Patients deprived of freedoms or under guardianship * Patient or family opponent of protocol participation * patient on curative anticoagulant for more than 48H00 * impossible Venous Doppler Echo

Locations (1)

Centre Hospitalier de Versailles

Le Chesnay, France

Outcomes

Primary Outcomes

Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Deep vein thrombosis at Doppler echo

Time frame: Day 0

Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Deep vein thrombosis at Doppler echo

Time frame: Day 7

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.